Dobutamine hydrochloride
SIGMA/D0676 - ≥98%
Synonym: (±)
CAS Number: 49745-95-1
Empirical Formula (Hill Notation): C18H23NO3 · HCl
Molecular Weight: 337.84
EC Number: 256-464-1
MDL Number: MFCD00153795
Linear Formula: C18H23NO3 · HCl
Product Type: Chemical
| assay | ≥98% |
| form | powder |
| InChI | 1S/C18H23NO3.ClH/c1-13(2- |
| InChI key | BQKADKWNRWCIJL-UHFFFAOYSA |
| originator | Eli Lilly |
| Quality Level | 200 ![]() |
| SMILES string | Cl[H].CC(CCc1ccc(O)cc1)NC |
| storage temp. | 2-8°C |
| Application: | Dobutamine hydrochloride has been used: • to treat mouse embryonic fibroblasts for cell death analysis • to inhibit TAZ (transcriptional coactivator with PDZ-binding motif)/YAP (Yes-associated protein) of Hippo pathway and study its effect on tumor cell proliferation • as β1-AR partial agonist to determine its effects on budding of endophilin-mRFP-positive structures by live-cell imaging |
| Biochem/physiol Actions: | Dobutamine is a synthetic catecholamine that stimulate the β1 -adrenoceptor receptor. It exhibits inotropic outcome on the myocardium. Dobutamine elevates contractility and is known to be useful in the condition of low blood pressure. |
| Features and Benefits: | This compound was developed by Eli Lilly . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H302 + H312 + H332 - H361fd |
| Precautionary statements | P201 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 - P308 + P313 |
| Hazard Codes | Xn |
| Risk Statements | 63-20/21/22 |
| Safety Statements | 22-26-36/37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥98% |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352116 |



